Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients


ESER K., ÖNDER H., SEZER E., ÇİL T., İNALTEKİN A., ÖZTÜRK B., ...Daha Fazla

Research Square Platform LLC, 2021 (Hakemli Dergi)